Researchers from The University of Manchester are asking women who took part in a pregnancy and epilepsy study to take part in a follow-up study.
The follow-up study is looking at neuropsychological outcomes in children aged 8-14 whose mothers were treated with anti-seizure medications during pregnancy.
The team would like to hear from women who took part in the NaME (Neurodevelopment of babies born to mothers with epilepsy) or EMPiRE (Anti-epileptic drug monitoring in pregnancy) studies and their children.
Participants in the NaME study had a researcher come to see them and their child when they were two years old to complete a developmental assessment. Those who took part in the EMPiRE study kept seizure diaries and gave blood samples to monitor medication levels during pregnancy.
The follow-up study will involve each participant and their child to carry out an assessment of the child’s thinking, sensory, social and behavioural development. Women will be asked to complete some questionnaires about their child.
The researchers say the appointment takes around 2.5 hours. It can be arranged for a time and place to suit the families and they will be reimbursed for their time.
To take part or ask any questions, contact the researchers at epi_follow@manchester.ac.uk.
More articles
